---
title: "Shandong Sanyuan Biotechnology Co.,Ltd. (301206.SZ)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/301206.SZ.md"
symbol: "301206.SZ"
name: "Shandong Sanyuan Biotechnology Co.,Ltd."
industry: "Packaged Foods and Meats"
---

# Shandong Sanyuan Biotechnology Co.,Ltd. (301206.SZ)

| Item | Detail |
|------|--------|
| Industry | Packaged Foods and Meats |
| Location | CN Market |
| Website | [www.sanyuanbz.com](https://www.sanyuanbz.com) |

## Company Profile

Shandong Sanyuan Biotechnology Co.,Ltd. engages in the research and development, production, and sale of erythritol and compound sugar products in China. Its products are used in table sugar, flavored sugar, and beverages; candy and chocolate food; baked food; health food; medical supplies; cosmetic...

## Financial Score

> *Longbridge Financial Score™ — Proprietary multi-factor rating model by [Longbridge](https://longbridge.com). This score is independently calculated by Longbridge and is not affiliated with any third-party rating agency.*
> Updated: 2026-02-14T04:30:08.000Z

**Overall: C (0.49)**

**Industry**: Packaged Foods and Meats

| Metric | Value |
|--------|-------|
| Industry Ranking | 92 / 137 |
| Industry Median | C |
| Industry Average | C |

- **Style**: Value - Stocks where the company's main business is in a mature stage.
- **Scale**: Small - The company's operation has a high degree of growth and volatility, making it easy to achieve high investment returns.

### Score Analysis

**Style Score**: 

#### Growth Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 1.63% |  |
| Net Profit YoY | -4.17% |  |

#### Value Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| P/B Ratio | 1.26 |  |
| Dividend Ratio | 5.53% |  |


**Size Score**: 

#### Market Cap Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Market Cap | 5.43B |  |

#### Revenue Score: 

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue | 674.10M |  |


**Multi Score**: C

#### Profit Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| ROE | 2.07% | C |
| Profit Margin | 13.55% | B |
| Gross Margin | 10.53% | E |

#### Growth Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Revenue YoY | 1.63% | C |
| Net Profit YoY | -4.17% | C |
| Total Assets YoY | -5.97% | D |
| Net Assets YoY | -4.69% | D |

#### Cash Score: C

| Indicator | Value | Rating |
|-----------|-------|--------|
| Cash Flow Margin | 737.94% | B |
| OCF YoY | 1.63% | C |

#### Operating Score: D

| Indicator | Value | Rating |
|-----------|-------|--------|
| Turnover | 0.15 | D |

#### Debt Score: A

| Indicator | Value | Rating |
|-----------|-------|--------|
| Gearing Ratio | 3.73% | A |


```chart-data:radar
{
  "title": "Longbridge Financial Score - Shandong Sanyuan Biotechnology Co.,Ltd.",
  "chart_type": "radar",
  "dimensions": [
    {
      "name": "Profit",
      "grade": "C",
      "indicators": [
        {
          "name": "ROE",
          "value": "2.07%",
          "rating": "C"
        },
        {
          "name": "Profit Margin",
          "value": "13.55%",
          "rating": "B"
        },
        {
          "name": "Gross Margin",
          "value": "10.53%",
          "rating": "E"
        }
      ]
    },
    {
      "name": "Growth",
      "grade": "C",
      "indicators": [
        {
          "name": "Revenue YoY",
          "value": "1.63%",
          "rating": "C"
        },
        {
          "name": "Net Profit YoY",
          "value": "-4.17%",
          "rating": "C"
        },
        {
          "name": "Total Assets YoY",
          "value": "-5.97%",
          "rating": "D"
        },
        {
          "name": "Net Assets YoY",
          "value": "-4.69%",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Cash",
      "grade": "C",
      "indicators": [
        {
          "name": "Cash Flow Margin",
          "value": "737.94%",
          "rating": "B"
        },
        {
          "name": "OCF YoY",
          "value": "1.63%",
          "rating": "C"
        }
      ]
    },
    {
      "name": "Operating",
      "grade": "D",
      "indicators": [
        {
          "name": "Turnover",
          "value": "0.15",
          "rating": "D"
        }
      ]
    },
    {
      "name": "Security",
      "grade": "A",
      "indicators": [
        {
          "name": "Gearing Ratio",
          "value": "3.73%",
          "rating": "A"
        }
      ]
    }
  ]
}
```

### Peer Comparison

| Rank | Name | Profit | Growth | Operation | Security | Cash | Rating |
|------|------|--------|--------|-----------|----------|------|--------|
| 01 | GAMBOL PET (SZ.301498) | B | B | A | A | B | A |
| 02 | MUYUAN (SZ.002714) | B | B | B | D | B | B |
| 03 | HAI TIAN (SH.603288) | A | B | B | A | C | B |
| 04 | WENS (SZ.300498) | B | C | A | C | B | B |
| 05 | SHUANGHUI (SZ.000895) | B | C | A | C | B | B |

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | 59.45 | 80/137 | 60.23 | 56.99 | 53.56 |
| PB | 1.26 | 13/137 | 1.36 | 1.30 | 1.24 |
| PS (TTM) | 8.06 | 131/137 | 9.01 | 8.53 | 8.08 |
| Dividend Yield | 5.53% | 6/137 | 4.75% | 4.52% | 2.47% |

## Institutional View

### Analyst Rating Distribution

> As of 2025-06-04T16:00:00.000Z

Total Analysts: **1**

| Rating | Count | Percentage |
|--------|-------|-----------|
| Buy | 0 | 0% |
| Overweight | 0 | 0% |
| Hold | 1 | 100% |
| Underweight | 0 | 0% |
| Sell | 0 | 0% |

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 26.84 |
| Highest Target | 32.00 |
| Lowest Target | 32.00 |

## References

- [Company Overview](https://longbridge.com/en/quote/301206.SZ/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/301206.SZ/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/301206.SZ/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.